Literature DB >> 11786384

Hormonal control of the transcription factor Pax8 and its role in the regulation of thyroglobulin gene expression in thyroid cells.

A Mascia1, L Nitsch, R Di Lauro, M Zannini.   

Abstract

The transcription factor Pax8 plays an important role in the expression of the differentiated phenotype of thyroid follicular cells. It has recently been shown that Pax8 is necessary for thyroglobulin (Tg) gene expression in the fully differentiated rat thyroid cell line PC. We have used the PC model system to investigate the role of Pax8 as a mediator of TSH regulation of Tg gene expression. We have demonstrated that Pax8 expression, as well as Tg expression, is severely reduced in cells grown in the absence of hormones and serum. The re-addition of TSH or forskolin to the culture medium is able to restore to wild-type levels the expression of both Pax8 and Tg. We have determined that the action of TSH/forskolin on Pax8 is at the transcriptional level. However, the re-expression of Pax8 can be observed several hours before that of Tg, suggesting that either another factor is needed or that Pax8 itself must be post-translationally modified by a newly synthesized protein to become active. To distinguish between these two possibilities we have stably transfected into PC cells an exogenous Pax8 that is expressed independently of TSH. Our results indicate that in these cells the Tg promoter is still dependent on TSH despite the constitutive presence of Pax8. Furthermore, we also show that in this condition Tg gene transcription requires de novo protein synthesis. In conclusion, TSH regulates the expression of Pax8 at a transcriptional level and also regulates the activity of Pax8 by controlling the expression of one or more as yet unknown factors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11786384     DOI: 10.1677/joe.0.1720163

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  8 in total

Review 1.  Pax-8-PPAR-γ fusion protein in thyroid carcinoma.

Authors:  Priyadarshini Raman; Ronald J Koenig
Journal:  Nat Rev Endocrinol       Date:  2014-07-29       Impact factor: 43.330

2.  TSH receptor function is required for normal thyroid differentiation in zebrafish.

Authors:  Robert Opitz; Emilie Maquet; Maxime Zoenen; Rajesh Dadhich; Sabine Costagliola
Journal:  Mol Endocrinol       Date:  2011-07-07

3.  An essential role for Pax8 in the transcriptional regulation of cadherin-16 in thyroid cells.

Authors:  Tiziana de Cristofaro; Tina Di Palma; Imma Fichera; Valeria Lucci; Luca Parrillo; Mario De Felice; Mariastella Zannini
Journal:  Mol Endocrinol       Date:  2011-12-01

4.  NF-kappaB p65 subunit mediates lipopolysaccharide-induced Na(+)/I(-) symporter gene expression by involving functional interaction with the paired domain transcription factor Pax8.

Authors:  Juan Pablo Nicola; Magalí Nazar; Iván Darío Mascanfroni; Claudia Gabriela Pellizas; Ana María Masini-Repiso
Journal:  Mol Endocrinol       Date:  2010-07-28

5.  Oncogenic ras blocks the cAMP pathway and dedifferentiates thyroid cells via an impairment of pax8 transcriptional activity.

Authors:  Maria Giuseppina Baratta; Immacolata Porreca; Roberto Di Lauro
Journal:  Mol Endocrinol       Date:  2009-03-12

6.  Pax8 modulates the expression of Wnt4 that is necessary for the maintenance of the epithelial phenotype of thyroid cells.

Authors:  Maria Grazia Filippone; Tina Di Palma; Valeria Lucci; Mariastella Zannini
Journal:  BMC Mol Biol       Date:  2014-09-30       Impact factor: 2.946

7.  PTEN-knockdown disrupts the morphology, growth pattern and function of Nthy-Ori 3-1 cells by downregulating PAX8 expression.

Authors:  Zhuo Sun; Jinqi Lu; Muyu Wu; Changli Ouyang; Yueping Xing; Xiancun Hou; Zhenduo Shi; Yongping Wu
Journal:  Oncol Lett       Date:  2019-10-31       Impact factor: 2.967

8.  VEGFR2 but not VEGFR3 governs integrity and remodeling of thyroid angiofollicular unit in normal state and during goitrogenesis.

Authors:  Jeon Yeob Jang; Sung Yong Choi; Intae Park; Do Young Park; Kibaek Choe; Pilhan Kim; Young Keum Kim; Byung-Joo Lee; Masanori Hirashima; Yoshiaki Kubota; Jeong-Won Park; Sheue-Yann Cheng; Andras Nagy; Young Joo Park; Kari Alitalo; Minho Shong; Gou Young Koh
Journal:  EMBO Mol Med       Date:  2017-06       Impact factor: 12.137

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.